Evidence map›Paper›PMID 40199887›Full record

ArticleCell death discovery2025

Metrnl protects intestinal barrier function by regulating tight junctions via the IKKβ/IκBα/NFκB/MLCK/MLC signaling pathway.

Zhi-Yong Li, Heng-Yu Luo, Fei Xu, Yao Xu, Chun-Hui Ma, Sai-Long Zhang, Sheng Xu, Yuan-Yuan Ma, Nan Li, Chao-Yu Miao

Abstract read
In one paragraph

Article in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Carbon dots derived fromFrontiers in molecular biosciences · 2026
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhi-Yong Li *Department of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, 200433, China. zhiyongli@smmu.edu.cn.ORCID http://orcid.org/0000-0001-6138-4712
Heng-Yu Luo *Department of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, 200433, China.
Fei XuDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, 200433, China.
Yao XuDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, 200433, China.
Chun-Hui MaDepartment of Pathology, Faculty of Medical Imaging, Second Military Medical University/Naval Medical University, Shanghai, 200433, China.
Sai-Long ZhangDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, 200433, China.
Sheng XuDepartment of Immunology, Second Military Medical University/Naval Medical University, Shanghai, 200433, China.
Yuan-Yuan MaSenior Department of Hematology, The Fifth Medical Center of People's Liberation Army(PLA), General Hospital, Beijing, 100010, China.
Nan LiDepartment of Immunology, Second Military Medical University/Naval Medical University, Shanghai, 200433, China.
Chao-Yu MiaoDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, 200433, China. cymiao@smmu.edu.cn.ORCID http://orcid.org/0000-0002-8176-3434

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82030110;82330117Natural Science Foundation of Shanghai (Natural Science Foundation of Shanghai Municipality) 23ZR1477400
6 · The paper itself

Abstract

Meteorin-like (Metrnl), also known as Subfatin, IL-41, or Cometin, is a secreted protein predominantly expressed in the intestinal epithelium. The intestinal barrier, primarily consisting of epithelial cells connected by tight junctions, is essential for maintaining gut homeostasis by preventing harmful substances from entering the body. Despite Metrnl's high expression in the intestine, its role in barrier function remains unclear. In this study, we investigated Metrnl's role in intestinal barrier function using both loss-of-function (using global and intestinal epithelium-specific knockout mice) and gain-of-function (using intestinal epithelium-specific overexpression mice) approaches. Our findings showed that Metrnl deficiency disrupted tight junctions between enterocytes and exacerbated endotoxin-induced barrier dysfunction. Mechanistically, Metrnl deficiency triggered activation of the IKKβ/IκBα/NFκB signaling pathway, leading to increased MLCK expression and MLC phosphorylation. The NFκB inhibitor PDTC reversed this effect both in vivo and in vitro. Macrophages played an essential role in Metrnl's intestinal barrier protective effects during endotoxemia, but were not necessary in burn-induced barrier injury, suggesting potential differences in mechanism between these conditions. Notably, recombinant Metrnl protein administration protected against barrier dysfunction, and genetic overexpression of Metrnl in enterocytes preserved barrier function and alleviated DSS-induced colitis. These findings establish Metrnl as a key regulator of intestinal barrier integrity through the IKKβ/IκBα/NFκB/MLCK/MLC pathway, highlighting its potential therapeutic value in treating barrier dysfunction disorders. Intestinal barrier dysfunction triggers, such as endotoxin and severe burns, may induce the release of Metrnl from vascular endothelium. This leads to an increase in circulating Metrnl. Both circulating Metrnl and local Metrnl inhibit inflammation and the IKKβ/IκBα/NFκB/MLCK/MLC signaling pathway in enterocytes, thereby protecting tight junctions from disruption caused by endotoxin or burns.

Identifiers

PMID40199887
PMCPMC11979045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.